BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22311412)

  • 1. Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.
    Dong H; Lu FE; Zhao L
    Chin J Integr Med; 2012 Feb; 18(2):152-60. PubMed ID: 22311412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
    Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway].
    Li HS; Feng Q; Xu LL; Chen SD; Li XM; Hu YY
    Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):546-51. PubMed ID: 19583937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A promising therapy for fatty liver disease: PCSK9 inhibitors.
    Han L; Wu L; Yin Q; Li L; Zheng X; Du S; Huang X; Bai L; Wang Y; Bian Y
    Phytomedicine; 2024 Jun; 128():155505. PubMed ID: 38547616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal medicines and nonalcoholic fatty liver disease.
    Yao H; Qiao YJ; Zhao YL; Tao XF; Xu LN; Yin LH; Qi Y; Peng JY
    World J Gastroenterol; 2016 Aug; 22(30):6890-905. PubMed ID: 27570425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Shi KQ; Fan YC; Liu WY; Li LF; Chen YP; Zheng MH
    Mol Biol Rep; 2012 Oct; 39(10):9715-22. PubMed ID: 22718512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
    Li H
    J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
    Liu C; Liao JZ; Li PY
    World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: a multicenter clinical trial.
    Fan JG;
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):375-80. PubMed ID: 15313672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial.
    Liu Q; Li X; Pan Y; Liu Q; Li Y; He C; Zheng N; Wang Y; Wang H; Wang Y; Sheng L; Zhang B; Shen T; Wu G; Li H; Wang X; Zhang W; Hu Y; Zhao Y
    Phytomedicine; 2024 Jul; 130():155398. PubMed ID: 38788390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal medicines for fatty liver diseases.
    Liu ZL; Xie LZ; Zhu J; Li GQ; Grant SJ; Liu JP
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009059. PubMed ID: 23975682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases.
    Li JY; Cao HY; Sun L; Sun RF; Wu C; Bian YQ; Dong S; Liu P; Sun MY
    World J Gastroenterol; 2017 Feb; 23(7):1125-1138. PubMed ID: 28275293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease.
    Zhou H; Ma C; Wang C; Gong L; Zhang Y; Li Y
    Eur J Pharmacol; 2021 May; 898():173976. PubMed ID: 33639194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese Medicinal Herbs Targeting the Gut-Liver Axis and Adipose Tissue-Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science.
    Zhang S; Wong YT; Tang KY; Kwan HY; Su T
    Front Endocrinol (Lausanne); 2020; 11():572729. PubMed ID: 33101207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
    Feng Q; Liu W; Baker SS; Li H; Chen C; Liu Q; Tang S; Guan L; Tsompana M; Kozielski R; Baker RD; Peng J; Liu P; Zhu R; Hu Y; Zhu L
    Oncotarget; 2017 Apr; 8(17):27820-27838. PubMed ID: 28416740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease].
    Pan YT; Xu FY; Yu XZ; Shang WB
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1109-1112. PubMed ID: 29027424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.